Campylobacter antimicrobial drug resistance among humans, broiler chickens, and pigs, France

Emerging Infectious Diseases

Volumn 13, Issue 2, 2007, Pages 259-266

  Gallay, Anne ^a   Prouzet Mauléon, Valérie ^b   Kempf, Isabelle ^c   Lehours, Philippe ^b   Labadi, Leila ^b   Camou, Christine ^b   Denis, Martine ^c   De Valk, Henriette ^a   Desenclos, Jean Claude ^a   Mégraud, Francis ^b  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b Centre National de Référence des Campylobacters et des Hélicobacters   (France)

^c Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM CULTURE; CAMPYLOBACTER; CHICKEN; CHILD; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; MALE; NEWBORN; NONHUMAN; POLICY; SWINE;

EID: 33846660745     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1302.060587     Document Type: Article

References (40)

1. Allos BM. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis. 2001;32:1201-6.
2. Nachamkin I, Blaser MJ. Campylobacter. 2nd ed. Washington: ASM Press; 2000.
3. Wheeler JG, Sethi D, Cowden JM, Wall PG, Rodrigues LC, Tompkins DS, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. BMJ. 1999;318:1046-50.
4. de Wit MA, Koopmans MP, Kortbeek LM, van Leeuwen NJ, Vinje J, van Duynhoven YT. Etiology of gastroenteritis in sentinel general practices in the Netherlands. Clin Infect Dis. 2001;33:280-8.
5. Hall G, Kirk MD, Becker N, Gregory JE, Unicomb L, Millard G, et al. Estimating foodborne gastroenteritis, Australia. Emerg Infect Dis. 2005;11:1257-64.
6. Samuel MC, Vugia DJ, Shallow S, Marcus R, Segler S, McGivern T, et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis. 2004;38(Suppl 3):S165-74.
7. Vaillant V, de Valk H, Baron E, Ancelle T, Colin P, Delmas MC, et al. Foodborne infections in France. Foodborne Pathog Dis. 2005;2:221-32.
8. Stern NJ, Hiett KL, Alfredsson GA, Kristinsson KG, Reiersen J, Hardardottir H, et al. Campylobacter spp. in Icelandic poultry operations and human disease. Epidemiol Infect. 2003;130:23-32.
9. Friedman CR, Hoekstra RM, Samuel M, Marcus R, Bender J, Shiferaw B, et al. Risk factors for sporadic Campylobacter infection in the United States: a case-control study in FoodNet sites. Clin Infect Dis. 2004;38(Suppl 3):S285-96.
10. Neimann J, Engberg J, Molbak K, Wegener HC. A case-control study of risk factors for sporadic Campylobacter infections in Denmark. Epidemiol Infect. 2003;130:353-66.
11. Kuschner RA, Trofa AF, Thomas RJ, Hoge CW, Pitarangsi C, Amato S, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis. 1995;21:536-41.
12. Endtz HP, Ruijs GJ. van KB, Jansen WH, van der RT, Mouton RP. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother. 1991;27:199-208.
13. Lucey B, Cryan B, O'Halloran F, Wall PG, Buckley T, Fanning S. Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin. Vet Rec. 2002;151:317-20.
14. Nachamkin I, Ung H, Li M. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982-2001. Emerg Infect Dis. 2002;8:1501-3.
15. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis. 2001;7:24-34.
16. Luber P, Wagner J, Hahn H, Bartelt E. Antimicrobial resistance in Campylobacter jejuni and Campylobacter coli strains isolated in 1991 and 2001-2002 from poultry and humans in Berlin, Germany. Antimicrob Agents Chemother. 2003;47:3825-30.
17. Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR, et al. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis. 2004;10:1102-9.
18. Davidson DJ. In the matter of enrofloxacin for poultry: withdrawal of approval of Bayer Corporation's new animal drug application 1 (NADA) 140-828 (Baytril). FDA Docket no. 00N-1571. 2004.
19. Gallay A, Simon F, Megraud F. Surveillance of human Campylobacter infections in France - part 2 - implementation of national surveillance. Euro Surveill. 2003;8:218.
20. Mégraud F. Les Infections à Campylobacter en France (1986-2000). Surveillance National des Maladies Infectieuses. 1998-2000;2003:133-5.
21. Mégraud F, Prouzet-Mauleon V. Evolution de la résistance des Campylobacters aux antibiotiques en France (1986-2002). Bull Epidémiol Heb. 2004;32-33:156-8.
22. Menard A, Dachet F, Prouzet-Mauleon V, Oleastro M, Megraud F. Development of a real-time fluorescence resonance energy transfer PCR to identify the main pathogenic Campylobacter spp. Clin Microbiol Infect. 2005;11:281-7.
23. National Center for Biotechnology Information. Basic Local Alignment Search Tool (BLAST) program. National Center for Biotechnology Information 2006 May 7 [cited 2006 Oct 17]. Available from http://www.ncbi.nlm.nih.gov/blast/
24. Société Française de Microbiologie. Recommandations du Comité de l'Antibiogramme de la Société Française de Microbiologie. Société Française de Microbiologie 2006 Feb 24 [cited 2006 Oct 17]. Available from http://www.sfm.asso.fr/nouv/general. php?pa=2
25. Avrain L, Humbert F, L'Hospitalier R, Sanders P, Vernozy-Rozand C, Kempf I. Antimicrobial resistance in Campylobacter from broilers: association with production type and antimicrobial use. Vet Microbiol. 2003;96:267-76.
26. Denis M, Soumet C, Rivoal K, Ermel G, Blivet D, Salvat G, et al. Development of a m-PCR assay for simultaneous identification of Campylobacter jejuni and C. coli. Lett Appl Microbiol. 1999;29:406-10.
27. Nylen G, Dunstan F, Palmer SR, Andersson Y, Bager F, Cowden J, et al. The seasonal distribution of Campylobacter infection in nine European countries and New Zealand. Epidemiol Infect. 2002;128:383-90.
28. Vandenberg O, Dediste A, Houf K, Ibekwem S, Souayah H, Cadranel S, et al. Arcobacter species in humans. Emerg Infect Dis. 2004;10:1863-7.
29. Takkinen J, Ammon A, Robstad O, Breuer T. European survey on Campylobacter surveillance and diagnosis 2001. Euro Surveill. 2003;8:207-13.
30. Gallay A, Simon F, Megraud F. Surveillance of human Campylobacter infections in France - part 1 - which data? A study of microbiological laboratories, 2000. Euro Surveill. 2003;8:213-7.
31. Desmonts MH, Dufour-Gesbert F, Avrain L, Kempf I. Antimicrobial resistance in Campylobacter strains isolated from French broilers before and after antimicrobial growth promoter bans. J Antimicrob Chemother. 2004;54:1025-30.
32. Udayamputhoor RS, Hariharan H, Van Lunen TA, Lewis PJ, Heaney S, Price L, et al. Effects of diet formulations containing proteins from different sources on intestinal colonization by Campylobacter jejuni in broiler chickens. Can J Vet Res. 2003;67:204-12.
33. Hopkins KL, Desai M, Frost JA, Stanley J, Logan JM. Fluorescent amplified fragment length polymorphism genotyping of Campylobacter jejuni and Campylobacter coli strains and its relationship with host specificity, serotyping, and phage typing. J Clin Microbiol. 2004;42:229-35.
34. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis. 2001;7:337-41.
35. Threlfall EJ, Ward LR, Frost JA, Willshaw GA. Spread of resistance from food animals to man - the UK experience. Acta Vet Scand Suppl. 2000;93:63-8.
36. Unicomb L, Ferguson J, Riley TV, Collignon P. Fluoroquinolone resistance in Campylobacter absent from isolates, Australia. Emerg Infect Dis. 2003;9:1482-3.
37. Iovine NM, Blaser MJ. Antimicrobial resistance in Campylobacter. Emerg Infect Dis. 2004;10:1346.
38. Moulin G, Roux S. Suivi des ventes de médicaments vétérinaires contenant des antibiotiques en France en 2002. Agence Française de Sécurité Sanitaire des Aliments. Report 30 Nov 2004. Available from http://www.afssa.fr/Ftp/Afssa/28169-28170.pdf
39. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med. 1999;340:1525-32.
40. Kassenborg HD, Smith KE, Vugia DJ, Rabatsky-Ehr T, Bates MR, Carter MA, et al. Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. Clin Infect Dis. 2004;38(Suppl 3):S279-84.